STAT
AUGUST 14, 2024
The World Health Organization on Wednesday declared the spread of mpox in multiple African countries a public health emergency of international concern, the second such declaration in the past two years called in response to transmission of the virus. The latest decision came on the recommendation of a panel of experts convened to advise WHO Director-General Tedros Adhanom Ghebreyesus on the issue.
PharmaVoice
AUGUST 15, 2024
A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 16, 2024
On Wednesday, 14th August, the World Health Organization (WHO) announced the mpox outbreak in Africa as a public health emergency of international concern (PHEIC). By Thursday, 15th August, the first case of the severe variant was reported in Sweden, marking its emergence outside of Africa.
BioPharma Dive
AUGUST 15, 2024
The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
AUGUST 14, 2024
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It proved to be a life-changing event: Two hours later as I was driving home, the shock of a sudden loud and high-pitched whistling nearly caused me to veer off the road. It was as if an audible dog whistle began blaring right next to me.
PharmaVoice
AUGUST 13, 2024
A series of executive turnovers at Gain Therapeutics this year precedes important early-stage Parkinson’s results that could change how the disease is treated.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
AUGUST 16, 2024
The vaccine didn’t spur a strong enough immune response against a particular flu strain in a Phase 3 trial, leading the companies to ponder adjustments.
STAT
AUGUST 15, 2024
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them. The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl
PharmaVoice
AUGUST 13, 2024
Immunic’s treatment has anti-inflammation, neuroprotection and antiviral effects plus a ‘benign’ safety profile that even seems to lower the risk of COVID-19 infection.
The Pharmacist
AUGUST 15, 2024
The National Pharmacy Association (NPA) is ‘hopeful’ about the new government’s support for the sector, but is planning another day of action to keep pharmacy ‘on the agenda’. ‘The new government has had lots of issues to deal with in its first few weeks. We want to make sure that we remind the government this […] The post Paul Rees: 'We have to keep pharmacy on the government's agenda' appeared first on The Pharmacist.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
AUGUST 13, 2024
Our longtime Finance Director Paul Bannister was a part of the fabric of pharmaphorum almost from the beginning and an integral part of keeping the publication running. And, most importantly, he was the soul of the place and a friend to all.
STAT
AUGUST 11, 2024
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels of the Food and Drug Administration’s rejection of the closely watched treatment for post-traumatic stress disorder. Many authors on the three studies are affiliated with the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) and its commercial spinout Lykos Therapeutics, including founder Rick Doblin, who spearheaded the decades-long efforts to win a
PharmaVoice
AUGUST 14, 2024
The German biotech is leveraging its mRNA platforms to develop a new class of cancer treatments that are necessary to lift the company’s flagging sales.
BioPharma Dive
AUGUST 12, 2024
Editors at Psychopharmacology cited "unethical conduct" that the study authors didn't disclose when submitting the papers. Lykos Therapeutics says it filed a complaint with a third party to review the way the journal came to its decision.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
AUGUST 13, 2024
With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.
STAT
AUGUST 12, 2024
If you twirl a bottle of alcohol and squint, you might see a text box with a warning. Usually in black and white, with letters two to three millimeters high, it reads: GOVERNMENT WARNING: (1) According to the Surgeon General, women should not drink alcoholic beverages during pregnancy because of the risk of birth defects. (2) Consumption of alcoholic beverages impairs your ability to drive a car or operate machinery, and may cause health problems.
PharmaVoice
AUGUST 12, 2024
Deals driven by obesity meds are fueling an M&A comeback.
The Pharmacist
AUGUST 16, 2024
The October start date for Covid and flu vaccinations will cause 'problems with capacity' for community pharmacies as they juggle increased prescriptions and seasonal ailments alongside the vaccination programme, the chief executive of the Independent Pharmacies Association (IPA) has warned. This comes as NHS England (NHSE) confirmed this week that the main flu and Covid […] The post October vaccination start could stretch pharmacy capacity, IPA warns appeared first on The Pharmacist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Commerce
AUGUST 16, 2024
In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, comments on other ways to limit ‘bad actors’ attempts to sneak counterfeit drugs into the supply chain, aside from the DSCSA.
STAT
AUGUST 16, 2024
Degree by degree, the earth’s temperature ticks up. Heat records fall as reliably as the sun sets. In July, the East Coast broiled. This week, Texas and its neighbors are feeling the burn. It’s been an absolute scorcher in the United States, the hottest summer on record. This summer might also be one of the coolest summers for the rest of your life.
PharmaVoice
AUGUST 16, 2024
The final negotiations slash drug prices between 38% and 79% for Medicare’s 2026 calendar year.
Pharmaceutical Business Review
AUGUST 14, 2024
The vaccine candidate is a virus-like particle (VLP)-based, adjuvanted vaccine designed for active immunisation against chikungunya virus (CHIKV) infection. This expedited review process is a significant step towards the vaccine’s potential approval for individuals aged 12 years and older, aiming to prevent disease caused by chikungunya virus infection.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
AUGUST 14, 2024
In this part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, describes the outcome of the joint public meeting held by the Partnership for DSCSA Governance and the FDA.
STAT
AUGUST 14, 2024
At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, “Every new patient on my schedule is under 45.” She replied, “Three of mine are … this is too many young people with cancer.” We felt as though we were in the trenches and didn’t know where the bullets were coming from.
BioPharma Dive
AUGUST 15, 2024
The layoffs are part of a larger reorganization that will also see the departure of Lykos’ founder, the psychedelics advocate Rick Doblin.
Med Ed 101
AUGUST 11, 2024
Benazepril and lisinopril are both ACE Inhibitors that are commonly used in practice. Lisinopril is the most frequently used ACE inhibitor. In this article, we will compare benazepril versus lisinopril and highlight some of the differences that may help guide the selection of one versus the other. Angiotensin-converting enzyme (ACE) inhibitors are a specific medication […] The post Benazepril Versus Lisinopril appeared first on Med Ed 101.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Express Pharma
AUGUST 16, 2024
FOPE and Pharma State Academy recently hosted, third session of their PULSE series on August 11, 2024, spotlighting “Quality Risk Management (QRM)” with a special focus on the Revised Schedule M. The session drew significant participation from across the pharmaceutical industry, underscoring the critical importance of risk management in ensuring product safety and regulatory compliance.
STAT
AUGUST 15, 2024
People with disabilities are largely excluded from clinical trials that could benefit them because federal agencies have failed to update rules that govern how trials are conducted or neglected to enforce existing laws that protect disabled Americans against discrimination, a new report has found. The National Council on Disability, an independent federal agency, released the report this week detailing how several federal agencies implicitly and explicitly exclude people with disabilities from c
Pharmaceutical Commerce
AUGUST 12, 2024
In this part of his Pharma Commerce video interview, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, discusses the impact technology has in relation to patients sticking to their medication plan.
pharmaphorum
AUGUST 15, 2024
FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.
BioPharma Dive
AUGUST 12, 2024
The clearance of Yorvipath for hypoparathyroidism was some time coming for Ascendis, which had resubmitted after receiving a rejection last year.
Expert insights. Personalized for you.
364 
Let's personalize your content